GLPBio

Salubrinal

Catalog No.: GC17331Purity:>99.50%
Salubrinal ist ein zellgÄngiger und selektiver Inhibitor der eIF2α-Dephosphorylierung.

Die Produkte sind ausschließlich für Forschungszwecke bestimmt. Nicht zur Anwendung am Menschen. Wir verkaufen nicht an Patienten.


Salubrinal
Cas No.: 405060-95-9
10mM (in 1mL DMSO)In Stock
$50.00
1
1mgIn Stock
$21.00
1
5mgIn Stock
$46.00
1
10mgIn Stock
$70.00
1
25mgIn Stock
$140.00
1
50mgIn Stock
$245.00
1
100mgIn Stock
$420.00
1

Zitate (Citations)

Für dieses Produkt sind derzeit keine Zitate verfügbar. Nachfolgend finden Sie ausgewählte Publikationen, die GlpBio-Produkte zitieren.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Beschreibung (Description)

Salubrinal is a potent and selective inhibitor of eukaryotic translation initiation factor 2α (eIF2α) dephosphorylation[1]. Salubrinal acts as a dual-specificity phosphatase 2 (Dusp2) inhibitor, inhibiting anti-collagen antibody-induced arthritis[2]. Salubrinal has anti-HSV-1 viral activity and inhibits the dephosphorylation of eIF2α mediated by the HSV-1 protein ICP34.5[3].

In vitro, treatment of human skin fibroblasts with Salubrinal (0-20μM) for 1h protected cells from UVB radiation-induced cell death in a dose-dependent manner and maintained intracellular Ca2+ homeostasis[4]. Treatment of bone marrow-derived cells isolated from mice with Salubrinal (1, 2, 5μM) for 6 days inhibited osteoclast differentiation and inhibited migration and adhesion of preosteoclasts in a dose- and time-dependent manner[5].

In vivo, Salubrinal (1mg/kg/day) was treated intraperitoneally in mice with traumatic brain injury (TBI) for 20 days, which effectively reduced TBI-induced plasma membrane permeability, reduced lesion volume, improved neurological deficits, and reduced ER stress-induced autophagy activation[6]. Salubrinal (1mg/kg) was treated intraperitoneally in rats with acute myocardial infarction (MI) for 30min, which increased myocardial eIF2α phosphorylation, reduced the expression of caspase-12 and C/EBP homologous protein (CHOP), and reduced myocardial cell apoptosis and infarct size[7].

References:
[1] Wang R, Sun D Z, Song C Q, et al. Eukaryotic translation initiation factor 2 subunit α (eIF2α) inhibitor salubrinal attenuates paraquat-induced human lung epithelial-like A549 cell apoptosis by regulating the PERK-eIF2α signaling pathway[J]. Toxicology In Vitro, 2018, 46: 58-65.
[2] Hamamura K, Nishimura A, Chen A, et al. Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis[J]. Cellular signalling, 2015, 27(4): 828-835.
[3] Bryant K F, Macari E R, Malik N, et al. ICP34. 5-dependent and-independent activities of salubrinal in herpes simplex virus-1 infected cells[J]. Virology, 2008, 379(2): 197-204.
[4] Ji C, Yang B, Huang S, et al. Salubrinal protects human skin fibroblasts against UVB-induced cell death by blocking endoplasmic reticulum (ER) stress and regulating calcium homeostasis[J]. Biochemical and biophysical research communications, 2017, 493(4): 1371-1376.
[5] Yokota H, Hamamura K, Chen A, et al. Effects of salubrinal on development of osteoclasts and osteoblasts from bone marrow-derived cells[J]. BMC musculoskeletal disorders, 2013, 14: 1-11.
[6] Wang Z, Gao C, Chen W, et al. Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model[J]. Neurobiology of learning and memory, 2019, 161: 12-25.
[7] Li R J, He K L, Li X, et al. Salubrinal protects cardiomyocytes against apoptosis in a rat myocardial infarction model via suppressing the dephosphorylation of eukaryotic translation initiation factor 2α[J]. Molecular Medicine Reports, 2015, 12(1): 1043-1049.

Protokoll (Protocol)

Cell experiment [1]:

Cell lines

Human skin fibroblasts

Preparation Method

Human skin fibroblasts were pretreated with 0-20μM Salubrinal for 1h and then irradiated with UVB (15mJ/cm2). Cell viability was determined by MTT.

Reaction Conditions

0-20μM; 1h

Applications

Salubrinal protects human skin fibroblasts against UVB radiation-induced cell death in a dose dependent manner.

Animal experiment [2]:

Animal models

Adult male ICR mice

Preparation Method

Mice were subjected to Traumatic brain injury (TBI) in the left part of the brain using a weightdrop controlled cortical impact device. After injury, the scalp was sutured and mice returned to their cages to recover from anesthesia. After TBI, mice were sacrificed 6 h, 1 d, 2 d, 3 d, 7 d, 10 d and 14 d after surgery, and control mice were sacrificed on day 2. The groups of this experiment were as follows: vehicle-treated sham group (Sha+Veh), Salubrinal-treated sham group (Sha+Sal), vehicletreated TBI group (TBI+Veh) and Salubrinal-treated TBI group (TBI+Sal). Salubrinal (1mg/kg, first solubilized in DMSO to 100mg/kg and then in saline to the final concentration) was administered by intraperitoneal injection 2h after the onset of TBI and subsequent daily dose for 2 or 21d after TBI. Solvent control mice received a vehicle injection (1% DMSO in saline) at the same time points after TBI. Sham animals also received vehicle or Salubirnal.

Dosage form

1mg/kg/day for 20 days; i.p.

Applications

Salubrinal ameliorated neurological deficits after TBI. Salubrinal reduced lesion volume after TBI. Salubrinal decreased TBI-induced ER stress-autophagic activation.

References:

[1]Ji C, Yang B, Huang S, et al. Salubrinal protects human skin fibroblasts against UVB-induced cell death by blocking endoplasmic reticulum (ER) stress and regulating calcium homeostasis[J]. Biochemical and biophysical research communications, 2017, 493(4): 1371-1376.

[2]Wang Z, Gao C, Chen W, et al. Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model[J]. Neurobiology of learning and memory, 2019, 161: 12-25.

Produktdokumente (Product Documents)

Purity:>99.50%Appearance:A solid

Chemische Eigenschaften (Chemical Properties)

CAS-Nr.
405060-95-9
Chemischer Name
(E)-3-phenyl-N-[2,2,2-trichloro-1-(quinolin-8-ylcarbamothioylamino)ethyl]prop-2-enamide
SMILES
C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3
Summenformel
C21H17Cl3N4OS
Molekulargewicht
479.81
Löslichkeit
≥ 48mg/mL in DMSO
Lagerung
4°C, protect from light
Allgemeine Hinweise
Wählen Sie anhand der Löslichkeitsdaten des Produkts ein geeignetes Lösungsmittel. Aliquotieren Sie die Stammlösung nach der Herstellung, um wiederholte Gefrier-Auftau-Zyklen zu vermeiden.
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Versandbedingungen
Evaluierungsmuster werden mit Kühlakkus versandt. Andere verfügbare Größen werden bei Raumtemperatur oder auf Anfrage mit Kühlakkus versandt.

Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit

g/mol

Reviews

Review for Salubrinal

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%